| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Phio Pharmaceuticals Corp. (PHIO) has 7 insiders with recent SEC Form 4 filings, including 6 buys and 0 sells. PHIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 411.4K | $527.0K | - | |
| CFO | 94.0K | $120.4K | - | |
| Dir | 45.7K | $58.5K | - | |
| Dir | 38.7K | $49.5K | - | |
| Dir | 37.8K | $48.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2015 | Cauwenbergh Geert | President &CEO | Buy | 2,000 | $1.24 | $2,487.44 | +1.2% | |
| Jan 22, 2015 | Bitterman Robert J | Director | Buy | 5,000 | $1.20 | $5,981.47 | +81.3% | |
| Jan 20, 2015 | Cauwenbergh Geert | President &CEO | Buy | 10,000 | $1.03 | $10,300.00 | +21.5% |